<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.2minutemedicine.com/feed/</title><link>https://www.2minutemedicine.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Thu, 29 Jan 2026 06:35:00 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Perioperative esketamine may improve postoperative pain and mood outcomes after cesarean section</title><link>https://www.2minutemedicine.com/perioperative-esketamine-may-improve-postoperative-pain-and-mood-outcomes-after-cesarean-section/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2018/02/doctor-patient-16-anesthesia-surgery-300x150.jpg</image_url><description>1. Intravenous esketamine provides effective adjunctive analgesia after cesarean delivery while also reducing postoperative inflammation and mood-rela...</description><pubDate>Thu, 29 Jan 2026 00:00:47 GMT</pubDate></item><item><title>Tenecteplase not associated with visual improvement in central retinal artery occlusion</title><link>https://www.2minutemedicine.com/tenecteplase-not-associated-with-visual-improvement-in-central-retinal-artery-occlusion/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/04/clot-CCWiki-300x150.jpg</image_url><description>1. In this randomized controlled trial of adults with central retinal artery occlusion, tenecteplase administration shortly after symptom onset did no...</description><pubDate>Wed, 28 Jan 2026 23:00:48 GMT</pubDate></item><item><title>Palbociclib as adjunct maintenance therapy prolongs progression-free survival in some types of metastatic breast cancer</title><link>https://www.2minutemedicine.com/palbociclib-as-adjunct-maintenance-therapy-prolongs-progression-free-survival-for-her2-positive-metastatic-breast-cancer/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/02/medication_edited-300x150.jpg</image_url><description>1. This randomized controlled trial found that, in patients with hormone-receptor-positive, HER2-positive metastatic breast cancer, the addition of pa...</description><pubDate>Wed, 28 Jan 2026 22:00:03 GMT</pubDate></item><item><title>Deepfake doctors and counterfeit injectables erode patient safety</title><link>https://www.2minutemedicine.com/deepfake-doctors-and-counterfeit-injectables-erode-patient-safety/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/01/injection_edited-e1441545841603-300x150.jpg</image_url><description>1. Deepfake clinicians and AI-shaped wellness content are blurring the line between medical advice and marketing in ways that patients may struggle to...</description><pubDate>Wed, 28 Jan 2026 17:36:46 GMT</pubDate></item><item><title>Sacituzumab govitecan plus pembrolizumab improves survival in advanced triple-negative breast cancer</title><link>https://www.2minutemedicine.com/sacituzumab-govitecan-plus-pembrolizumab-improves-survival-in-advanced-triple-negative-breast-cancer/</link><image_url>https://www.2minutemedicine.com/wp-content/uploads/2015/05/Mri_of_breast_cancer_edited-300x150.jpg</image_url><description>1. Among patients with previously untreated programmed death-ligand 1 positive, triple-negative breast cancer, first-line sacituzumab govitecan plus p...</description><pubDate>Wed, 28 Jan 2026 16:30:38 GMT</pubDate></item></channel></rss>